3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Wright, S.W., Carlo, A.A., Danley, D.E., Hageman, D.L., Karam, G.A., Mansour, M.N., McClure, L.D., Pandit, J., Schulte, G.K., Treadway, J.L., Wang, I.-K., Bauer, P.H.(2003) Bioorg Med Chem Lett 13: 2055-2058
- PubMed: 12781194 
- DOI: https://doi.org/10.1016/s0960-894x(03)00310-x
- Primary Citation of Related Structures:  
1LEV - PubMed Abstract: 
3-(2-Carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid (MDL-29951), an antagonist of the glycine site of the NMDA receptor, has been found to be an allosteric inhibitor of the enzyme fructose 1,6-bisphosphatase. The compound binds at the AMP regulatory site by X-ray crystallography. This represents a new approach to inhibition of fructose 1,6-bisphosphatase and serves as a lead for further drug design.
Organizational Affiliation: 
Pfizer Central Research, Eastern Point Road, Box 8220-3141, Groton, CT 06340, USA. stephen_w_wright@groton.pfizer.com